This mechanism involves the PI3K/Akt signaling pathway, and human breast cancer cells with overexpression and amplification of HER-2/neu have been shown to make increased use of the PI3K/Akt signaling pathway [7]. This evidence concerns the gene AKT1 and breast carcinoma.